We examined the effects of cathepsin inhibitor 1 (CATI-1), a selective inhi
bitor of cysteine cathepsins, on human leukemia and lymphoma cells. CATI-1
induced apoptosis in all 12 cell lines tested. Apoptosis of CATI-1-treated
leukemia/lymphoma cells was caspase-independent, p53-independent, BAX-indep
endent as well as MAP kinase-independent. Our findings provide unprecedente
d experimental evidence that cathepsins play a pivotal role for the surviva
l of human leukemia/lymphoma cells. Therefore, cathepsin inhibitors may pro
vide the basis for new treatment programs against leukemia and lymphoma.